Cure My Disease

Don't miss your cure!

 Log in / Sign up

Two-Year watch: how safe is this MS injection?

NCT ID NCT04940065

Completed Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study monitored patients with relapsing or progressive multiple sclerosis (MS) who were taking Kesimpta injections for two years. The main goal was to track side effects and see how well the drug worked at preventing relapses and slowing disability. Researchers followed 367 patients to collect real-world safety information and measure changes in their MS symptoms.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSING REMITTING MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Novartis Investigative Site

    Ichinomiya, Aichi-ken, 491-0041, Japan

  • Novartis Investigative Site

    Nagakute, Aichi-ken, 480-1195, Japan

  • Novartis Investigative Site

    Nagoya, Aichi-ken, 453-0815, Japan

  • Novartis Investigative Site

    Nagoya, Aichi-ken, 457 8510, Japan

  • Novartis Investigative Site

    Nagoya, Aichi-ken, 467-8602, Japan

  • Novartis Investigative Site

    Tokoname, Aichi-ken, 479-0868, Japan

  • Novartis Investigative Site

    Toyohashi, Aichi-ken, 441-8570, Japan

  • Novartis Investigative Site

    Hachinohe, Aomori, 031-0011, Japan

  • Novartis Investigative Site

    Hachinohe, Aomori, 039-1104, Japan

  • Novartis Investigative Site

    Hirosaki, Aomori, 036 8563, Japan

  • Novartis Investigative Site

    Chiba, Chiba, 2608677, Japan

  • Novartis Investigative Site

    Ichikawa, Chiba, 272-8513, Japan

  • Novartis Investigative Site

    Narita, Chiba, 286-8523, Japan

  • Novartis Investigative Site

    Yachiyo, Chiba, 276-8524, Japan

  • Novartis Investigative Site

    Tōon, Ehime, 791-0295, Japan

  • Novartis Investigative Site

    Fukuoka, Fukuoka, 812-8582, Japan

  • Novartis Investigative Site

    Iizuka, Fukuoka, 820-8505, Japan

  • Novartis Investigative Site

    Kitakyushu, Fukuoka, 802-8555, Japan

  • Novartis Investigative Site

    Kurume, Fukuoka, 830-0011, Japan

  • Novartis Investigative Site

    Omuta, Fukuoka, 836-8566, Japan

  • Novartis Investigative Site

    Gifu, Gifu, 501-1194, Japan

  • Novartis Investigative Site

    Maebashi, Gunma, 371 8511, Japan

  • Novartis Investigative Site

    Maebashi, Gunma, 371-0847, Japan

  • Novartis Investigative Site

    Fukuyama, Hiroshima, 720-0825, Japan

  • Novartis Investigative Site

    Asahikawa, Hokkaido, 070-8530, Japan

  • Novartis Investigative Site

    Hakodate, Hokkaido, 041-0821, Japan

  • Novartis Investigative Site

    Sapporo, Hokkaido, 060 8648, Japan

  • Novartis Investigative Site

    Sapporo, Hokkaido, 060-8543, Japan

  • Novartis Investigative Site

    Sapporo, Hokkaido, 063-0005, Japan

  • Novartis Investigative Site

    Sapporo, Hokkaido, 065-0021, Japan

  • Novartis Investigative Site

    Sunagawa, Hokkaido, 0730196, Japan

  • Novartis Investigative Site

    Kobe, Hyōgo, 650-0047, Japan

  • Novartis Investigative Site

    Mito, Ibaraki, 310-0011, Japan

  • Novartis Investigative Site

    Tsuchiura, Ibaraki, 300-0028, Japan

  • Novartis Investigative Site

    Ichinoseki, Iwate, 021-0871, Japan

  • Novartis Investigative Site

    Ichinoseki, Iwate, 029-0192, Japan

  • Novartis Investigative Site

    Morioka, Iwate, 020-8505, Japan

  • Novartis Investigative Site

    Kagoshima, Kagoshima-ken, 890 8520, Japan

  • Novartis Investigative Site

    Kagoshima, Kagoshima-ken, 890-8760, Japan

  • Novartis Investigative Site

    Kanoya, Kagoshima-ken, 893-0023, Japan

  • Novartis Investigative Site

    Kawasaki, Kanagawa, 216-8511, Japan

  • Novartis Investigative Site

    Sagamihara, Kanagawa, 252-0375, Japan

  • Novartis Investigative Site

    Yokohama, Kanagawa, 227-8501, Japan

  • Novartis Investigative Site

    Yokohama, Kanagawa, 232 0024, Japan

  • Novartis Investigative Site

    Yokohama, Kanagawa, 236-0004, Japan

  • Novartis Investigative Site

    Yokohama, Kanagawa, 247-8581, Japan

  • Novartis Investigative Site

    Nankoku, Kochi, 783 8505, Japan

  • Novartis Investigative Site

    Kyoto, Kyoto, 602-8566, Japan

  • Novartis Investigative Site

    Kyoto, Kyoto, 616-8255, Japan

  • Novartis Investigative Site

    Kesennuma, Miyagi, 988-0085, Japan

  • Novartis Investigative Site

    Sendai, Miyagi, 980 8574, Japan

  • Novartis Investigative Site

    Sendai, Miyagi, 983 8512, Japan

  • Novartis Investigative Site

    Nagano, Nagano, 380-8582, Japan

  • Novartis Investigative Site

    Nagano, Nagano, 381-8551, Japan

  • Novartis Investigative Site

    Sasebo, Nagasaki, 857-1195, Japan

  • Novartis Investigative Site

    Kashihara, Nara, 634 8522, Japan

  • Novartis Investigative Site

    Tenri, Nara, 632-8552, Japan

  • Novartis Investigative Site

    Niigata, Niigata, 950-1197, Japan

  • Novartis Investigative Site

    Ōita, Oita Prefecture, 870-8511, Japan

  • Novartis Investigative Site

    Kurashiki, Okayama-ken, 710-0826, Japan

  • Novartis Investigative Site

    Okayama, Okayama-ken, 700-8558, Japan

  • Novartis Investigative Site

    Fujiidera, Osaka, 583-0014, Japan

  • Novartis Investigative Site

    Moriguchi, Osaka, 570-8507, Japan

  • Novartis Investigative Site

    Osaka, Osaka, 556-0015, Japan

  • Novartis Investigative Site

    Sakai, Osaka, 590-0197, Japan

  • Novartis Investigative Site

    Sakai, Osaka, 5928555, Japan

  • Novartis Investigative Site

    Suita, Osaka, 565 0871, Japan

  • Novartis Investigative Site

    Kawagoe, Saitama, 350 8550, Japan

  • Novartis Investigative Site

    Koshigaya, Saitama, 343-8555, Japan

  • Novartis Investigative Site

    Saitama, Saitama, 330-8553, Japan

  • Novartis Investigative Site

    Wako, Saitama, 351-0102, Japan

  • Novartis Investigative Site

    Ohtsu, Shiga, 520-2192, Japan

  • Novartis Investigative Site

    Ōmihachiman, Shiga, 523-0082, Japan

  • Novartis Investigative Site

    Izumo, Shimane, 693 8501, Japan

  • Novartis Investigative Site

    Hamamatsu, Shizuoka, 431-3192, Japan

  • Novartis Investigative Site

    Oyama, Tochigi, 323-0827, Japan

  • Novartis Investigative Site

    Shimotsuga Gun, Tochigi, 321-0293, Japan

  • Novartis Investigative Site

    Shimotsuke, Tochigi, 329-0403, Japan

  • Novartis Investigative Site

    Bunkyo Ku, Tokyo, 113 8655, Japan

  • Novartis Investigative Site

    Bunkyo Ku, Tokyo, 113-8431, Japan

  • Novartis Investigative Site

    Edogawa City, Tokyo, 134-0086, Japan

  • Novartis Investigative Site

    Fuchū, Tokyo, 183-0042, Japan

  • Novartis Investigative Site

    Kiyose, Tokyo, 204-8585, Japan

  • Novartis Investigative Site

    Minato-ku, Tokyo, 105-8471, Japan

  • Novartis Investigative Site

    Nakano City, Tokyo, 164-8607, Japan

  • Novartis Investigative Site

    Shinjuku Ku, Tokyo, 160-0023, Japan

  • Novartis Investigative Site

    Shinjuku-ku, Tokyo, 160 8582, Japan

  • Novartis Investigative Site

    Toyama, Toyama, 930-0194, Japan

  • Novartis Investigative Site

    Wakayama, Wakayama, 641-8510, Japan

  • Novartis Investigative Site

    Kudamatsu, Yamaguchi, 744-0075, Japan

  • Novartis Investigative Site

    Shūnan, Yamaguchi, 745-8522, Japan

  • Novartis Investigative Site

    Ube, Yamaguchi, 755-8505, Japan

  • Novartis Investigative Site

    Aomori, 030 8553, Japan

  • Novartis Investigative Site

    Fukuoka, 810-0001, Japan

  • Novartis Investigative Site

    Hiroshima, 734 8530, Japan

  • Novartis Investigative Site

    Kobe, 650-0017, Japan

  • Novartis Investigative Site

    Kyoto, 600-8558, Japan

  • Novartis Investigative Site

    Kyoto, 606 8507, Japan

  • Novartis Investigative Site

    Niigata, 951 8520, Japan

  • Novartis Investigative Site

    Osaka, 530-8480, Japan

  • Novartis Investigative Site

    Osaka, 543-8555, Japan

  • Novartis Investigative Site

    Osaka, 545-8586, Japan

  • Novartis Investigative Site

    Osaka, 558-8558, Japan

Conditions

Explore the condition pages connected to this study.

ACTIVE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS RELAPSING REMITTING MULTIPLE SCLEROSIS